RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 47 filers reported holding RECRO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,058 | -66.9% | 23,577 | -16.1% | 0.00% | – |
| Q1 2023 | $33,454 | -18.4% | 28,113 | +57.1% | 0.00% | – |
| Q2 2021 | $41,000 | +13.9% | 17,892 | +37.7% | 0.00% | – |
| Q1 2021 | $36,000 | +12.5% | 12,991 | +14.4% | 0.00% | – |
| Q4 2020 | $32,000 | -42.9% | 11,356 | -7.9% | 0.00% | – |
| Q2 2020 | $56,000 | -31.7% | 12,332 | +20.9% | 0.00% | -100.0% |
| Q2 2014 | $82,000 | – | 10,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |